01875 TOT BIOPHARM-B
- 2.040
- +0.170+9.09%
TOT BIOPHARM-B News
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: THIRD FORM OF PROXY
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: SECOND FORM OF PROXY
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: FORM OF PROXY
TOT BIOPHARM-B: CERTAIN UNAUDITED FINANCIAL INFORMATIONFOR THE THREE MONTHS ENDED 31 MARCH 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
TOT BIOPHARM-B: FIRST LETTER AND REPLY FORM - ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
Analysis
Price Target
No Data
